1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the
Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and
Secondary Sources
2.5. Forecasting
Methodology
2.6. Data Triangulation
& Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5.
Clinical Trial Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical
Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of
Pipeline, By Status
5.6. Breakdown of
Pipeline, By Study Type
5.7. Breakdown of
Pipeline, By Country
5.8. Clinical Trials Heat
Map
6. Europe Biomarker
Technologies Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Test Type (Solid
Biopsy, Liquid Biopsy)
6.2.2. By Technology (Immunoassay, DDPCR, Next Generation Sequencing (NGS), Mass
Spectrometry, DHPLC, Others)
6.2.3. By Product (Consumables, Instruments, Services, Software/Informatics)
6.2.4. By Indication (Oncology, Infectious Diseases, Autoimmune
Disorders, Cardiovascular Disorders, Others)
6.2.5. By End User
(Pharmaceutical Companies, Hospitals, CROs, Diagnostic Labs, Research Institutes)
6.2.6. By Application (Clinical Diagnostics, Research, Drug Discovery
& Development)
6.2.7. By Company (2022)
6.2.8. By Country
6.3. Market Map
7. France Biomarker
Technologies Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Test Type
7.2.2. By Technology
7.2.3. By Product
7.2.4. By Application
8. Germany Biomarker
Technologies Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Test Type
8.2.2. By Technology
8.2.3. By Product
8.2.4. By Application
9. United Kingdom
Biomarker Technologies Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Test Type
9.2.2. By Technology
9.2.3. By Product
9.2.4. By Application
10. Italy Biomarker
Technologies Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Test Type
10.2.2. By Technology
10.2.3. By Product
10.2.4. By Application
11. Spain Biomarker
Technologies Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Test Type
11.2.2. By Technology
11.2.3. By Product
11.2.4. By Application
12. Finland Biomarker
Technologies Market Outlook
12.1.
Market Size & Forecast
12.1.1. By Value
12.2.
Market Share & Forecast
12.2.1. By Test Type
12.2.2. By Technology
12.2.3. By Product
12.2.4. By Application
13. Greece Biomarker
Technologies Market Outlook
13.1.
Market Size & Forecast
13.1.1. By Value
13.2.
Market Share & Forecast
13.2.1. By Test Type
13.2.2. By Technology
13.2.3. By Product
13.2.4. By Application
14.
Portugal Biomarker Technologies Market Outlook
14.1.
Market Size & Forecast
14.1.1. By Value
14.2.
Market Share & Forecast
14.2.1. By Test Type
14.2.2. By Technology
14.2.3. By Product
14.2.4. By Application
15. Bulgaria Biomarker
Technologies Market Outlook
15.1.
Market Size & Forecast
15.1.1. By Value
15.2.
Market Share & Forecast
15.2.1. By Test Type
15.2.2. By Technology
15.2.3. By Product
15.2.4. By Application
16. Croatia Biomarker
Technologies Market Outlook
16.1.
Market Size & Forecast
16.1.1. By Value
16.2.
Market Share & Forecast
16.2.1. By Test Type
16.2.2. By Technology
16.2.3. By Product
16.2.4. By Application
17. Market Dynamics
17.1.
Drivers
17.2.
Challenges
18. Market Trends & Developments
19. Competitive
Landscape
19.1.
Competition Outlook
19.2.
Regional Players Profiled (Leading Companies)
19.2.1.
F. Hoffmann-La Roche AG
19.2.2.
Merck KGAA
19.2.3.
Beckman Coulter, Inc.
19.2.4.
Qiagen N.V.
19.2.5.
Biomérieux SA
19.2.6.
Bio-Rad Laboratories N.V.
19.2.7.
Siemens AG
19.2.8.
Abbott Molecular Inc.
19.2.9.
Danaher Corporation
19.2.10.
Epigenomics
AG
20.
Strategic Recommendations
(Note: The companies list can be
customized based on the client requirements.)